首页> 外文期刊>Analytical Sciences >Binding Study of Semotiadil and Levosemotiadil with Human Serum Albumin Using High-Performance Frontal Analysis
【24h】

Binding Study of Semotiadil and Levosemotiadil with Human Serum Albumin Using High-Performance Frontal Analysis

机译:高效额叶分析法研究艾美脲和左艾美汀与人血清白蛋白的结合

获取原文
       

摘要

High-performance frontal analysis (HPFA) wasapplied to investigate the binding properties of semotiadil(R-isomer, Ca-channel blocker) and levosemotiadil (S-isomer,Ca- and Na-channel blocker), an enantiomeric pair of drugs under devel-opment, to human serum albumin (HSA). An on-line HPLC systemconsisting of a HPFA column, an extraction column and an analytical HPLC column was used to determine the unbound concentrations of theseenantiomers. The experimental data were subjected to Scatchard analyses to estimate the binding parameters. The binding affinity of levosemo-tiadil(K=6.59×105 M-1, n=0.97) is aboutthree-times stronger than that of semotiadil (K=2.15×105M-1, n=0.99). These results did not change in thepresence of warfarin, but were significantly decreased by the addition ofdiazepam, indicating that both enantiomers are bound at the diazepam siteon HSA molecule.
机译:高效的前沿分析(HPFA)用于研究药物Semotiadil(R-异构体,Ca-通道阻滞剂)和左旋莫托地尔(S-异构体,Ca-和Na-通道阻滞剂)的对映体对药物的结合特性。选项,是针对人血清白蛋白(HSA)。由HPFA柱,萃取柱和分析HPLC柱组成的在线HPLC系统用于确定这些对映体的未结合浓度。对实验数据进行Scatchard分析以估计结合参数。左旋噻吩甲啶(K = 6.59×105 M-1,n = 0.97)的结合亲和力比阿莫西地啶(K = 2.15×105M-1,n = 0.99)约强三倍。这些结果在华法林的存在下没有改变,但是通过加入地西p而明显降低,表明这两种对映体都结合在HSA分子的地西epa部位。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号